Workday WDAY Captures Attention as Potential AI Growth Driver T1 Energy TE Surges 42 as Analyst Remains Bullish Despite ShortSeller Allegations Aramco Transfers Malaysian Refining Complex to Petronas in Portfolio Optimization Move Prediction Markets Spark Legal Clash Between US States and Federal Regulators Strait of Hormuz Attack Highlights Rising Geopolitical Risks for Oil Tanker Shipping AI Data Center Boom Strains Power Grid Raising Utility Costs for Consumers Village Farms International VFF Q1 2026 Earnings EPS Misses Estimates Slightly Amid Undisclosed Revenue ENVB Q4 2024 Earnings EPS Misses Estimates No Revenue Reported CDP Q1 2026 Earnings EPS Beat Amid Steady Defense Demand CMRC Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines Citius Oncology Q1 2026 Earnings Wide EPS Miss Highlights PreRevenue Challenges SWBI Q1 2026 Earnings EPS Beats Estimates Despite Challenging Market Conditions Infinity Natural Resources INR Holds Steady Near Support Targets Resistance Breakout Boyd Gaming BYD Shows Resilience with 173 Gain Testing Key Resistance at 8471 Millennium Group International MGIH Edges Lower Amidst Consolidation Near Key Support Swvl Holdings Corp Warrants SWVLW Approach Penny Levels Amid Continued Weakness United Parks Resorts PRKS Gains 26 as Stock Approaches Key Resistance Level Micron Technology Surpasses 1 Trillion Market Cap Following UBS Price Target Upgrade Acadian Asset Management Inc AAMI Q1 2026 Earnings Strong EPS Beat Signals Resilience in Volatile Markets AO Smith AOS Holds Near Support as Stock Slips 055 DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending Banco De Chile ADS BCH Q4 2025 Earnings EPS Misses Estimates Amid Challenging Operating Environment Shattuck Labs Q1 2026 Earnings NarrowerThanExpected Loss Amid Pipeline Progress Target Hospitality Corp TH Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges POWW Q1 2026 Earnings Profitability Surprise as EPS Turns Positive CVU Q1 2021 Earnings EPS Surges Past Estimates Stock Gains Prelude Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances